Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol ED50 with different esketamine doses for painless gastrointestinal endoscopy in adults
ChiCTR2100044567Phase 4Recruiting
- Sponsor
- Shanxi Bethune Hospital
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of propofol in procedural pain (4 arms), sponsored by Shanxi Bethune Hospital. Primary endpoint: Median effective concentration (ED50) of propofol. Started Apr 2021; status: recruiting.
02
Drugs
propofol
03
Conditions
procedural pain
Beyond the preview
Go deeper on ChiCTR2100044567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100044567.